Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00771
|
|||||
| Drug Name |
Droperidol
|
|||||
| Synonyms |
1-(1-(3-(p-Fluorobenzoyl)propyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone; 1-(1-(4-(4-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridinyl)-1,3-dihydro-2H-benzimidazol-2-one; 1-(1-(4-(p-Fluorophenyl)-4-oxobutyl)-1,2,3,6-tetrahydro-4-pyridyl)-2-benzimidazolinone; 1-1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl-2-benzimidazolinone; 1-[1-[3-(p-Fluorobenzoyl)propyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 1-[1-[4-(p-F; 1-[1-[4-(p-Fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; 1-{1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydropyridin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one; 2-Benzimidazolinone, 1-[1-[3-(p-fluorobenz; 3-[1-[4-(4-fluorophenyl)-4-oxobutyl]-3,6-dihydro-2H-pyridin-4-yl]-1H-benzimidazol-2-one; Component of Innovar; DHBP; Dehidrobenzperidol; Dehydrobenzoperidol; Dehydrobenzperidol; Deidrobenzperidolo; Dihidrobenzperidol; Dridol; Dridol (TN); Droleptan; Droleptan (TN); Droperidol (JP15/USP/INN); Droperidol [USAN:INN:BAN:JAN]; Droperidolo; Droperidolo [DCIT]; Droperidolum; Droperidolum [INN-Latin]; Dropletan (TN); HS-0065; Halkan; INAPSINE (TN); Ina.psi.n; Ina.psi.ne; Inappin; Inapsin; Inapsine; Inapsine (TN); Innovan; Innovar-vet; Ino.psi.n; Inopsin; Inoval; Janssen Brand of Droperidol; Kern Brand of Droperidol; Leptanal; Leptofen; Luorophenyl)-4-oxobutyl]-1,2,3,6-tetrahydro-4-pyridyl]-2-benzimidazolinone; McN-JR 4749; McN-JR-4749; Properidol; R 4749; R-4749; R4749; Sintodril; Sintosian; Taylor Brand of Droperidol; Thalamanol; Thalamonal; Vetkalm
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Therapeutic Class |
Antipsychotic Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C22H22FN3O2
|
|||||
| Canonical SMILES |
C1CN(CC=C1N2C3=CC=CC=C3NC2=O)CCCC(=O)C4=CC=C(C=C4)F
|
|||||
| InChI |
InChI=1S/C22H22FN3O2/c23-17-9-7-16(8-10-17)21(27)6-3-13-25-14-11-18(12-15-25)26-20-5-2-1-4-19(20)24-22(26)28/h1-2,4-5,7-11H,3,6,12-15H2,(H,24,28)
|
|||||
| InChIKey |
RMEDXOLNCUSCGS-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 548-73-2
|
|||||
| Pharmaceutical Properties | Molecular Weight | 379.4 | Topological Polar Surface Area | 52.6 | ||
| Heavy Atom Count | 28 | Rotatable Bond Count | 6 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 4 | |||
| XLogP |
3.5
|
|||||
| PubChem CID | ||||||
| TTD Drug ID | ||||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.